摘要
目的: 了解恶性疟原虫抗青蒿琥酯株对氯喹及氨酚喹 (阿莫地喹) 有无交叉抗性及其与青蒿琥酯联合使用是否有增效作用。方法: 用Rieckm ann 体外微量法比较青蒿琥酯敏感株与抗性株恶性疟原虫对氯喹和氨酚喹的敏感性。结果: 氯喹对青蒿琥酯敏感株与抗性株原虫的ID50 分别为90.9 及112.0 nm ol/L, ID95 均为320.0nm ol/L; 氨酚喹ID50 分别为50.9 及133.5 nm ol/L, ID95 均为320.0 nm ol/L。在联合用药组中, 青蒿琥酯及氯喹的完全抑制浓度(ID95) 分别为3.2 及20.0 nm ol/L,为单用组的1/125 和1/16;青蒿琥酯及氨酚喹的ID95 分别为3.2 及5.0 nm ol/L, 为单用组的1/125 和1/64。结论: 抗青蒿琥酯恶性疟原虫对氯喹、氨酚喹无明显交叉抗性,青蒿琥酯与这2 种药物联用在体外测试有明显增效作用。
AIM: To explore the in vitro sensitivity of artesunate\|sensitive and \|resistant Plasmodium falciparum to chloroquine and amodiaquine and to observe the effect of artesunate combined with chloroquine and artesunate combined with amodiaquine on artesunate\|resistant P.falciparum. METHODS: The sensitivity of the artesunate\|sensitive and \|resistant P.falciparum to chloroquine and amodiaquine and their combination with artesunate was compared by using Rieckmann′s in vitro micro\|technique.RESULTS: The ID\-\{50\} and ID\-\{95\} values of chloroquine, amodiaquine and artesunete were 90\^9, 50\^9, 9\^6 nmol/L and 320\^0、320\^0, 40\^0 nmol/L to the artesunate\|sensitive P.falciparum respectively and were 112\^0, 133\^5, 85\^1 nmol/L and 320\^0, 320\^0, 400\^0 nmol/L to artesunate\|resistant P.falciparum, respectively. When artesunate was combined with chloroquine, the ID\-\{50\} values of the 2 drugs were 3\^2 and 20\^0 nmol/L to the artesunate\|resistant P.falciparum. When artesunate was combined with amodiaquine, the ID\-\{95\} values of the 2 drugs were 3\^2 and 5\^0 nmol/L to the artesunate\|resistant P.falciparum, respectively. CONCLUSION: The artesunate\|resistant P.falciparum has no cross resistance to chloroquine and amodiaquine, however, artesunate combined with chloroquine or amodiaquine exhibit an apparent synergistic effect in vitro.\;
出处
《中国寄生虫学与寄生虫病杂志》
CAS
CSCD
北大核心
1999年第6期353-355,共3页
Chinese Journal of Parasitology and Parasitic Diseases
基金
联合国开发计划署/世界银行/世界卫生组织热带病研究与培训特别规划!(TDR
ID-971144)
云南省卫生厅资助项目!(No.
关键词
恶性疟原虫
青蒿琥酯
氯喹
氨酚喹
药敏试验
Plasmodium falciparum
artesunate
chloroquine
amodiaquine
combination of drugs
in vitro test